These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22703880)

  • 1. Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1.
    Zhou J; Tawk M; Tiziano FD; Veillet J; Bayes M; Nolent F; Garcia V; Servidei S; Bertini E; Castro-Giner F; Renda Y; Carpentier S; Andrieu-Abadie N; Gut I; Levade T; Topaloglu H; Melki J
    Am J Hum Genet; 2012 Jul; 91(1):5-14. PubMed ID: 22703880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid ceramidase deficiency associated with spinal muscular atrophy with progressive myoclonic epilepsy.
    Gan JJ; Garcia V; Tian J; Tagliati M; Parisi JE; Chung JM; Lewis R; Baloh R; Levade T; Pierson TM
    Neuromuscul Disord; 2015 Dec; 25(12):959-63. PubMed ID: 26526000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy with progressive myoclonic epilepsy linked to mutations in ASAH1.
    Yildiz EP; Yesil G; Bektas G; Caliskan M; Tatlı B; Aydinli N; Ozmen M
    Clin Neurol Neurosurg; 2018 Jan; 164():47-49. PubMed ID: 29169047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1.
    Giráldez BG; Guerrero-López R; Ortega-Moreno L; Verdú A; Carrascosa-Romero MC; García-Campos Ó; García-Muñozguren S; Pardal-Fernández JM; Serratosa JM
    Neuromuscul Disord; 2015 Mar; 25(3):222-4. PubMed ID: 25578555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASAH1 pathogenic variants associated with acid ceramidase deficiency: Farber disease and spinal muscular atrophy with progressive myoclonic epilepsy.
    Elsea SH; Solyom A; Martin K; Harmatz P; Mitchell J; Lampe C; Grant C; Selim L; Mungan NO; Guelbert N; Magnusson B; Sundberg E; Puri R; Kapoor S; Arslan N; DiRocco M; Zaki M; Ozen S; Mahmoud IG; Ehlert K; Hahn A; Gokcay G; Torcoletti M; Ferreira CR
    Hum Mutat; 2020 Sep; 41(9):1469-1487. PubMed ID: 32449975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy associated with progressive myoclonus epilepsy.
    Topaloglu H; Melki J
    Epileptic Disord; 2016 Sep; 18(S2):128-134. PubMed ID: 27647482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum.
    Najafi A; Tasharrofi B; Zandsalimi F; Rasulinezhad M; Ghahvechi Akbari M; Zamani G; Ashrafi MR; Heidari M
    Ital J Pediatr; 2023 Jun; 49(1):64. PubMed ID: 37280710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy.
    Dyment DA; Sell E; Vanstone MR; Smith AC; Garandeau D; Garcia V; Carpentier S; Le Trionnaire E; Sabourdy F; Beaulieu CL; Schwartzentruber JA; McMillan HJ; ; Majewski J; Bulman DE; Levade T; Boycott KM
    Clin Genet; 2014 Dec; 86(6):558-63. PubMed ID: 24164096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1.
    Rubboli G; Veggiotti P; Pini A; Berardinelli A; Cantalupo G; Bertini E; Tiziano FD; D'Amico A; Piazza E; Abiusi E; Fiori S; Pasini E; Darra F; Gobbi G; Michelucci R
    Epilepsia; 2015 May; 56(5):692-8. PubMed ID: 25847462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASAH1-related disorders: Description of 15 novel pediatric patients and expansion of the clinical phenotype.
    Mahmoud IG; Elmonem MA; Zaki MS; Ramadan A; Al-Menabawy NM; El-Gamal A; Mansour L; Issa MY; Abdel-Hamid MS; Abdel-Hady S; Khalifa I; Ibrahim A; Solyom A; Rolfs A; Selim L
    Clin Genet; 2020 Dec; 98(6):598-605. PubMed ID: 32875576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five patients with spinal muscular atrophy-progressive myoclonic epilepsy (SMA-PME): a novel pathogenic variant, treatment and review of the literature.
    Karimzadeh P; Najmabadi H; Lochmuller H; Babaee M; Dehdahsi S; Miryounesi M; Amirsalari S; Rayegani SM; Tonekaboni SH
    Neuromuscul Disord; 2022 Oct; 32(10):806-810. PubMed ID: 36309462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study.
    Filosto M; Aureli M; Castellotti B; Rinaldi F; Schiumarini D; Valsecchi M; Lualdi S; Mazzotti R; Pensato V; Rota S; Gellera C; Filocamo M; Padovani A
    Eur J Hum Genet; 2016 Nov; 24(11):1578-1583. PubMed ID: 27026573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and genetics in non-5q spinal muscular atrophy caused by acid ceramidase deficiency.
    Axente M; Shelby ES; Mirea A; Sporea C; Badina M; Padure L; Ion DA
    J Med Life; 2021; 14(3):424-428. PubMed ID: 34377212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal muscular atrophy and Farber disease due to ASAH1 variants: A case report.
    Lee BH; Mongiovi P; Levade T; Marston B; Mountain J; Ciafaloni E
    Am J Med Genet A; 2020 Oct; 182(10):2369-2371. PubMed ID: 32627310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-transcriptome sequencing in blood provides a diagnosis of spinal muscular atrophy with progressive myoclonic epilepsy.
    Kernohan KD; Frésard L; Zappala Z; Hartley T; Smith KS; Wagner J; Xu H; McBride A; Bourque PR; Consortium CRC; Bennett SAL; Dyment DA; Boycott KM; Montgomery SB; Warman Chardon J
    Hum Mutat; 2017 Jun; 38(6):611-614. PubMed ID: 28251733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ASAH1 Variants Causing Spinal Muscular Atrophy Phenotype.
    Wander A; Meena AK; Ghangoriya PK; Chakrabarty B; Jauhari P; Gulati S
    Indian J Pediatr; 2023 Dec; ():. PubMed ID: 38079070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions.
    Kleynerman A; Rybova J; Faber ML; McKillop WM; Levade T; Medin JA
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content.
    Kyriakou K; Lederer CW; Kleanthous M; Drousiotou A; Malekkou A
    Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32111095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of a novel splice site variant in the ASAH1 gene.
    Yan S; Fu F; Zhou H; Huang R; Wang Y; Liao C
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2317. PubMed ID: 37962265
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.